Label: EPINEPHRINE injection

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Drug Application Authorized Generic

Drug Label Information

Updated May 30, 2025

If you are a consumer or patient please visit this version.

  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use EPINEPHRINE INJECTION safely and effectively. See full prescribing information for EPINEPHRINE INJECTION. EPINEPHRINE ...
  • Table of Contents
    Table of Contents
  • 1 INDICATIONS AND USAGE
    Epinephrine injection is indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which includes bees, wasps ...
  • 2 DOSAGE AND ADMINISTRATION
    2.1 Recommended Dosage According to - Patient Body Weight - Patients greater than or equal to 30 kg (approximately 66 pounds or more): 0.3 mg - Patients 15 kg to 30 kg (33 pounds to 66 pounds) ...
  • 3 DOSAGE FORMS AND STRENGTHS
    Injection: 0.3 mg (0.3 mg/0.3 mL) of clear and colorless solution in single-dose pre-filled auto-injector
  • 4 CONTRAINDICATIONS
    None.
  • 5 WARNINGS AND PRECAUTIONS
    5.1 Emergency Treatment - Epinephrine injection is intended for immediate administration as emergency supportive therapy and is not intended as a substitute for immediate medical care. In ...
  • 6 ADVERSE REACTIONS
    Due to the lack of randomized, controlled clinical trials of epinephrine for the treatment of anaphylaxis, the true incidence of adverse reactions associated with the systemic use of epinephrine ...
  • 7 DRUG INTERACTIONS
    Cardiac Glycosides, Diuretics, and Anti-arrhythmics - Patients who receive epinephrine while concomitantly taking cardiac glycosides, diuretics, or anti-arrhythmics should be observed carefully ...
  • 8 USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy - Risk Summary - There are no available human data on the use of epinephrine injection in pregnant women to inform a drug-associated risk of adverse developmental outcomes. In ...
  • 10 OVERDOSAGE
    Overdosage of epinephrine may produce extremely elevated arterial pressure, which may result in cerebrovascular hemorrhage, particularly in elderly patients. Overdosage may also result in ...
  • 11 DESCRIPTION
    Epinephrine injection, USP 0.3 mg and 0.15 mg is an auto-injector and a combination product containing drug and device components. Each epinephrine injection, USP 0.3 mg delivers a single dose of ...
  • 12 CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action - Epinephrine acts on both alpha- and beta-adrenergic receptors. 12.2 Pharmacodynamics - Through its action on alpha-adrenergic receptors, epinephrine lessens the ...
  • 13 NONCLINICAL TOXICOLOGY
    13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility - Long-term studies to evaluate the carcinogenic potential of epinephrine have not been conducted. Epinephrine and other catecholamines ...
  • 16 HOW SUPPLIED/STORAGE AND HANDLING
    Carton containing two epinephrine injection, USP 0.3 mg single-dose pre-filled auto-injectors: NDC: 70518-2048-00 - PACKAGING: 2 in 1 CARTON, 1 in 1 CASE, 0.3 mL in 1 SYRINGE GLASS, TYPE 0 - Storage ...
  • 17 PATIENT COUNSELING INFORMATION
    See FDA-Approved Patient Labeling (Patient Information and Instructions for Use) A healthcare provider should review the patient instructions and operation of epinephrine injection, in detail ...
  • Patient Information
    EPINEPHRINE injection (ep-in-eph-rine), for intramuscular or subcutaneous use - For allergic emergencies (anaphylaxis) Read this Patient Information leaflet carefully before you use epinephrine ...
  • Instructions for Use
    EPINEPHRINE injection (ep-in-eph-rine) for intramuscular or subcutaneous use - For allergic emergencies (anaphylaxis) Read this Instructions for Use carefully before you useepinephrine injection and ...
  • PRINCIPAL DISPLAY PANEL
    DRUG: epinephrine - GENERIC: epinephrine - DOSAGE: INJECTION - ADMINSTRATION: SUBCUTANEOUS - NDC: 70518-2048-0 - PACKAGING: 2 in 1 CARTON - PACKAGING: 1 in 1 CASE - PACKAGING: 0.3 mL in 1 SYRINGE, GLASS - ACTIVE ...
  • INGREDIENTS AND APPEARANCE
    Product Information